RDIF, ChemRar launch final stage of Favipiravir clinical tests - PRIME Business News Agency - All News Politics Economy Business Wire Financial Wire Oil Gas Chemical Industry Power Industry Metals Mining Pulp Paper Agro Commodities Transport Automobile Construction Real Estate Telecommunications Engineering Hi-Tech Consumer Goods Retail Calendar Our Features Interviews Opinions Press Releases

RDIF, ChemRar launch final stage of Favipiravir clinical tests

Лаборатория03MOSCOW, May 22 (PRIME) -- The Russian Direct Investment Fund (RDIF) and medical research group ChemRar have started the final stage of clinical tests of the Favipiravir drug that may be efficient in treatment of the COVID-19 coronavirus, the RDIF said in a statement on Friday.

“The Healthcare Ministry approved transition into the final stage of tests on May 21 with expansion of the group of patients to 330 people from 60 people and with involvement of new scientific and medical centers. Thus, the tests of the drug will continue and will cover patients in 30 centers in nine regions of Russia. The RDIF and ChemRar sent a request to the ministry asking for an accelerated registration procedure of the Favipiravir drug,” the statement read.

According to the RDIF, Favipiravir produced no new side effects, and body temperature of 68% patients who took the drug normalized in three days, while body temperature of patients in the control group normalized in six days on average. Remission of viral activity in the bodies of people who took the drug occurred in four days, while the bodies of people that underwent usual therapy coped with the virus in nine days.

After the first four days of treatment with Favipiravir, 65% patients out of 40 were tested negative for the coronavirus, doubling the result of the standard therapy group. The amount of people who tested negative for the coronavirus grew to 35 out of 40 as of the 10th day of the Favipiravir treatment, the RDIF said.

End %%md/jst%%

22.05.2020 11:06
Share |
To report an error select text and press Ctrl+Enter
Central Bank Official Rate
1W 1M 1Y
EUR 93.0237 +1.5447 30 sep
USD 79.6845 +1.0132 30 sep
Stock Market Indices
1D 1W 1M 1Y
rtsi 1187.18 -0.72 17:04 24 sep
micex 2910.99 -0.19 17:04 24 sep
Stock Quotes in RUR
1D 1W 1M 1Y
gazp 177.00 -1.12 23:49 24 sep
lkoh 4456.00 -1.61 23:49 24 sep
rosn 370.75 -1.08 23:49 24 sep
sber 228.50 -0.60 23:49 24 sep
MICEX Ruble Trading
1D 1W 1M 1Y
EURTD 89.7700 +0.5500 14:59 24 sep
USDTD 76.8125 +0.6125 17:44 24 sep